
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment
Mackenzie Bender, Alex McPherson, Catherine M. Phelps, et al.
Cell (2023) Vol. 186, Iss. 9, pp. 1846-1862.e26
Open Access | Times Cited: 297
Mackenzie Bender, Alex McPherson, Catherine M. Phelps, et al.
Cell (2023) Vol. 186, Iss. 9, pp. 1846-1862.e26
Open Access | Times Cited: 297
Showing 1-25 of 297 citing articles:
Targeting gut microbiota and metabolism as the major probiotic mechanism - An evidence-based review
Teng Ma, Xin Shen, Xuan Shi, et al.
Trends in Food Science & Technology (2023) Vol. 138, pp. 178-198
Open Access | Times Cited: 131
Teng Ma, Xin Shen, Xuan Shi, et al.
Trends in Food Science & Technology (2023) Vol. 138, pp. 178-198
Open Access | Times Cited: 131
Probiotics, prebiotics, and postbiotics in health and disease
Jing Ji, Weilin Jin, Shuang‐Jiang Liu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 126
Jing Ji, Weilin Jin, Shuang‐Jiang Liu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 126
γδ T cells: origin and fate, subsets, diseases and immunotherapy
Yi Hu, Qinglin Hu, Yongsheng Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 104
Yi Hu, Qinglin Hu, Yongsheng Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 104
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Andrew Maltez Thomas, Marine Fidelle, Bertrand Routy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 583-603
Closed Access | Times Cited: 65
Andrew Maltez Thomas, Marine Fidelle, Bertrand Routy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 583-603
Closed Access | Times Cited: 65
Bifidobacterium mechanisms of immune modulation and tolerance
Samuel J. Gavzy, Allison Kensiski, Zachariah L Lee, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 65
Samuel J. Gavzy, Allison Kensiski, Zachariah L Lee, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 65
Gut microbial metabolite facilitates colorectal cancer development via ferroptosis inhibition
Weiwei Cui, Meng Guo, Dong Liu, et al.
Nature Cell Biology (2024) Vol. 26, Iss. 1, pp. 124-137
Closed Access | Times Cited: 59
Weiwei Cui, Meng Guo, Dong Liu, et al.
Nature Cell Biology (2024) Vol. 26, Iss. 1, pp. 124-137
Closed Access | Times Cited: 59
Intratumoural microbiota: a new frontier in cancer development and therapy
Yaqi Cao, Hui Xia, Xueyun Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 59
Yaqi Cao, Hui Xia, Xueyun Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 59
Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8+ T cell effector functions
Jingjing Cong, Pianpian Liu, Zili Han, et al.
Immunity (2024) Vol. 57, Iss. 4, pp. 876-889.e11
Closed Access | Times Cited: 58
Jingjing Cong, Pianpian Liu, Zili Han, et al.
Immunity (2024) Vol. 57, Iss. 4, pp. 876-889.e11
Closed Access | Times Cited: 58
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
Yu-Ling Xiao, Yue Gong, Ying-Jia Qi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 56
Yu-Ling Xiao, Yue Gong, Ying-Jia Qi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 56
Ferroptosis: principles and significance in health and disease
Fangquan Chen, Rui Kang, Daolin Tang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 44
Fangquan Chen, Rui Kang, Daolin Tang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 44
Role of the microbiota in response to and recovery from cancer therapy
Stephen J. Blake, Yochai Wolf, Ben Boursi, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 308-325
Closed Access | Times Cited: 41
Stephen J. Blake, Yochai Wolf, Ben Boursi, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 308-325
Closed Access | Times Cited: 41
Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy
Xing Kang, Harry Cheuk-Hay Lau, Jun Yu
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101478-101478
Open Access | Times Cited: 36
Xing Kang, Harry Cheuk-Hay Lau, Jun Yu
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101478-101478
Open Access | Times Cited: 36
Cancer metabolism and carcinogenesis
Jianqiang Yang, Chloe Shay, Nabil F. Saba, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 33
Jianqiang Yang, Chloe Shay, Nabil F. Saba, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 33
Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies
Jindong Xie, Manqing Liu, Xinpei Deng, et al.
iMeta (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 31
Jindong Xie, Manqing Liu, Xinpei Deng, et al.
iMeta (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 31
Dopamine receptor D2 confers colonization resistance via microbial metabolites
Samantha A. Scott, Jingjing Fu, Pamela V. Chang
Nature (2024) Vol. 628, Iss. 8006, pp. 180-185
Open Access | Times Cited: 20
Samantha A. Scott, Jingjing Fu, Pamela V. Chang
Nature (2024) Vol. 628, Iss. 8006, pp. 180-185
Open Access | Times Cited: 20
Broadening oncological boundaries: the intratumoral microbiota
Ying‐Qi Lu, Han Qiao, Xi-Rong Tan, et al.
Trends in Microbiology (2024) Vol. 32, Iss. 8, pp. 807-822
Open Access | Times Cited: 17
Ying‐Qi Lu, Han Qiao, Xi-Rong Tan, et al.
Trends in Microbiology (2024) Vol. 32, Iss. 8, pp. 807-822
Open Access | Times Cited: 17
Achieving healthy aging through gut microbiota-directed dietary intervention: Focusing on microbial biomarkers and host mechanisms
Yue Xiao, Yingxuan Feng, Jianxin Zhao, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 17
Yue Xiao, Yingxuan Feng, Jianxin Zhao, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 17
ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion
Shouyan Deng, Yibo Zhang, Huanbin Wang, et al.
Cell (2024) Vol. 187, Iss. 9, pp. 2305-2323.e33
Closed Access | Times Cited: 15
Shouyan Deng, Yibo Zhang, Huanbin Wang, et al.
Cell (2024) Vol. 187, Iss. 9, pp. 2305-2323.e33
Closed Access | Times Cited: 15
Microbial Metabolites and Gut Immunology
Tadashi Takeuchi, Yumiko Nakanishi, Hiroshi Ohno
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 153-178
Closed Access | Times Cited: 15
Tadashi Takeuchi, Yumiko Nakanishi, Hiroshi Ohno
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 153-178
Closed Access | Times Cited: 15
Engineered Bacteria for Disease Diagnosis and Treatment Using Synthetic Biology
Kai Jin, Yi Huang, Hailong Che, et al.
Microbial Biotechnology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Kai Jin, Yi Huang, Hailong Che, et al.
Microbial Biotechnology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Scratching promotes allergic inflammation and host defense via neurogenic mast cell activation
Andrew W. Liu, Y. Zhang, Chien-Sin Chen, et al.
Science (2025) Vol. 387, Iss. 6733
Closed Access | Times Cited: 2
Andrew W. Liu, Y. Zhang, Chien-Sin Chen, et al.
Science (2025) Vol. 387, Iss. 6733
Closed Access | Times Cited: 2
The gut microbiome and cancer response to immune checkpoint inhibitors
Francesca S. Gazzaniga, Dennis L. Kasper
Journal of Clinical Investigation (2025) Vol. 135, Iss. 3
Open Access | Times Cited: 2
Francesca S. Gazzaniga, Dennis L. Kasper
Journal of Clinical Investigation (2025) Vol. 135, Iss. 3
Open Access | Times Cited: 2
Lymphodepletion – an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle
Benno Lickefett, Lulu Chu, Valentin Ortiz-Maldonado, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 39
Benno Lickefett, Lulu Chu, Valentin Ortiz-Maldonado, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 39
Precision Medicine in Oral Health and Diseases: A Systematic Review
Giuseppina Malcangi, Assunta Patano, Mariafrancesca Guglielmo, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 5, pp. 725-725
Open Access | Times Cited: 25
Giuseppina Malcangi, Assunta Patano, Mariafrancesca Guglielmo, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 5, pp. 725-725
Open Access | Times Cited: 25
Melanoma and microbiota: Current understanding and future directions
Bertrand Routy, Tanisha Jackson, Laura Mählmann, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 16-34
Open Access | Times Cited: 23
Bertrand Routy, Tanisha Jackson, Laura Mählmann, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 16-34
Open Access | Times Cited: 23